287 Oxaliplatin, a third‐generation platinum containing chemotherapeutic agent, has a key role in the management of colorectal cancer, both in adjuvant and metastatic settings. It also finds use in gastrointestinal… Click to show full abstract
287 Oxaliplatin, a third‐generation platinum containing chemotherapeutic agent, has a key role in the management of colorectal cancer, both in adjuvant and metastatic settings. It also finds use in gastrointestinal primaries of other locations. Although serious hypersensitivities and anaphylaxis to oxaliplatin occur rarely, further treatment is considerably compromised in such situations. In this regard, many desensitization protocols for oxaliplatin have been used in the past to warrant continuation of chemotherapy with the drug. We report a case of a young female with metastatic colorectal cancer who developed a hypersensitivity reaction to oxaliplatin and was successfully desensitized using a modified approach.
               
Click one of the above tabs to view related content.